RosA significantly reduced LPS-induced TNF-α, IL-6, and IL-1β production; RosA plays an anti-inflammatory effect on the acute lung injury in mice by inhibiting ERK/MAPK signaling in a dose-dependent manner. This evidence concerns the gene TNF and injury.